Igor Nasonkin
Co-Founder & CEO Phythera Therapeutics
Seminars
Thursday 29th January 2026
Leveraging Retinal Organoids to Advance Animal-Free Drug Testing for Ocular Cancer
4:00 pm
- Developing multi-molecular therapeutics to enhance efficacy against late-stage ocular melanoma compared to single-drug approaches
- Harnessing nature-derived compounds to discover novel anti-cancer agents for safer and more effective ocular therapeutics
- Adopting FDA-compliant organoid systems to eliminate animal testing while meeting FDA Modernization Act 2.0 requirements
